-
1
-
-
0042198675
-
B-type natriuretic peptide in cardiovascular disease
-
de Lemos J.A., McGuire D.K., Drazner M.H. B-type natriuretic peptide in cardiovascular disease. Lancet. 362:2003;316-322
-
(2003)
Lancet
, vol.362
, pp. 316-322
-
-
De Lemos, J.A.1
McGuire, D.K.2
Drazner, M.H.3
-
2
-
-
0037130155
-
Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure
-
Maisel A.S., Krishnaswamy P., Nowak R.M., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 347:2002;161-167
-
(2002)
N Engl J Med
, vol.347
, pp. 161-167
-
-
Maisel, A.S.1
Krishnaswamy, P.2
Nowak, R.M.3
-
3
-
-
0033812338
-
Profile of plasma N-terminal proBNP following acute myocardial infarction: Correlation with left ventricular systolic dysfunction
-
Talwar S., Squire I.B., Downie P.F., et al. Profile of plasma N-terminal proBNP following acute myocardial infarction Correlation with left ventricular systolic dysfunction. Eur Heart J. 21:2000;1514-1521
-
(2000)
Eur Heart J
, vol.21
, pp. 1514-1521
-
-
Talwar, S.1
Squire, I.B.2
Downie, P.F.3
-
4
-
-
0027210868
-
Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction
-
Morita E., Yasue H., Yoshimura M., et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation. 88:1993;82-91
-
(1993)
Circulation
, vol.88
, pp. 82-91
-
-
Morita, E.1
Yasue, H.2
Yoshimura, M.3
-
5
-
-
0027312397
-
Plasma brain natriuretic peptide as an indicator for angiotensin- converting enzyme inhibition after myocardial infarction
-
Motwani J.G., McAlpine H., Kennedy N., Struthers A.D. Plasma brain natriuretic peptide as an indicator for angiotensin-converting enzyme inhibition after myocardial infarction. Lancet. 341:1993;1109-1113
-
(1993)
Lancet
, vol.341
, pp. 1109-1113
-
-
Motwani, J.G.1
McAlpine, H.2
Kennedy, N.3
Struthers, A.D.4
-
6
-
-
0029948712
-
Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction: Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide
-
Omland T., Aakvaag A., Bonarjee V.V., et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation. 93:1996;1963-1969
-
(1996)
Circulation
, vol.93
, pp. 1963-1969
-
-
Omland, T.1
Aakvaag, A.2
Bonarjee, V.V.3
-
7
-
-
0029979053
-
Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction
-
Arakawa N., Nakamura M., Aoki H., Hiramori K. Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction. J Am Coll Cardiol. 27:1996;1656-1661
-
(1996)
J Am Coll Cardiol
, vol.27
, pp. 1656-1661
-
-
Arakawa, N.1
Nakamura, M.2
Aoki, H.3
Hiramori, K.4
-
8
-
-
0032546646
-
Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: New neurohormonal predictors of left ventricular function and prognosis after myocardial infarction
-
Richards A.M., Nicholls M.G., Yandle T.G., et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin New neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation. 97:1998;1921-1929
-
(1998)
Circulation
, vol.97
, pp. 1921-1929
-
-
Richards, A.M.1
Nicholls, M.G.2
Yandle, T.G.3
-
9
-
-
0032987484
-
Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction
-
the Christchurch Cardioendocrine Research Group, Richards A.M., Nicholls M.G., Yandle T.G., et al. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. Heart. 81:1999;114-120
-
(1999)
Heart
, vol.81
, pp. 114-120
-
-
Richards, A.M.1
Nicholls, M.G.2
Yandle, T.G.3
-
10
-
-
0037046221
-
Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: Results of the ENTIRE-(TIMI) 23 trial
-
Antman E.M., Louwerenburg H.W., Baars H.F., et al. Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction Results of the ENTIRE-(TIMI) 23 trial. Circulation. 105:2002;1642-1649
-
(2002)
Circulation
, vol.105
, pp. 1642-1649
-
-
Antman, E.M.1
Louwerenburg, H.W.2
Baars, H.F.3
-
11
-
-
0035499002
-
ST segment resolution as a tool for assessing the efficacy of reperfusion therapy
-
de Lemos J.A., Braunwald E. ST segment resolution as a tool for assessing the efficacy of reperfusion therapy. J Am Coll Cardiol. 38:2001;1283-1294
-
(2001)
J Am Coll Cardiol
, vol.38
, pp. 1283-1294
-
-
De Lemos, J.A.1
Braunwald, E.2
-
12
-
-
0034035024
-
Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: A TIMI 11B substudy
-
Morrow D.A., Rifai N., Tanasijevic M.J., Wybenga D.R., de Lemos J.A., Antman E.M. Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes A TIMI 11B substudy. Clin Chem. 46:2000;453-460
-
(2000)
Clin Chem
, vol.46
, pp. 453-460
-
-
Morrow, D.A.1
Rifai, N.2
Tanasijevic, M.J.3
Wybenga, D.R.4
De Lemos, J.A.5
Antman, E.M.6
-
13
-
-
0031746866
-
C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: A TIMI 11A substudy
-
Morrow D.A., Rifai N., Antman E.M., et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes A TIMI 11A substudy. J Am Coll Cardiol. 31:1998;1460-1465
-
(1998)
J Am Coll Cardiol
, vol.31
, pp. 1460-1465
-
-
Morrow, D.A.1
Rifai, N.2
Antman, E.M.3
-
14
-
-
0035807597
-
The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes
-
de Lemos J.A., Morrow D.A., Bentley J.H., et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med. 345:2001;1014-1021
-
(2001)
N Engl J Med
, vol.345
, pp. 1014-1021
-
-
De Lemos, J.A.1
Morrow, D.A.2
Bentley, J.H.3
-
15
-
-
0344608881
-
Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18
-
Morrow D.A., de Lemos J.A., Sabatine M.S., et al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. J Am Coll Cardiol. 41:2003;1264-1272
-
(2003)
J Am Coll Cardiol
, vol.41
, pp. 1264-1272
-
-
Morrow, D.A.1
De Lemos, J.A.2
Sabatine, M.S.3
-
16
-
-
0032704686
-
Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction
-
the GUSTO III Investigators, Ohman E.M., Armstrong P.W., White H.D., et al. Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. Am J Cardiol. 84:1999;1281-1286
-
(1999)
Am J Cardiol
, vol.84
, pp. 1281-1286
-
-
Ohman, E.M.1
Armstrong, P.W.2
White, H.D.3
-
17
-
-
0030855262
-
C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction
-
Anzai T., Yoshikawa T., Shiraki H., et al. C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. Circulation. 96:1997;778-784
-
(1997)
Circulation
, vol.96
, pp. 778-784
-
-
Anzai, T.1
Yoshikawa, T.2
Shiraki, H.3
-
18
-
-
0038120013
-
B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction
-
Richards A.M., Nicholls M.G., Espiner E.A., et al. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation. 107:2003;2786-2792
-
(2003)
Circulation
, vol.107
, pp. 2786-2792
-
-
Richards, A.M.1
Nicholls, M.G.2
Espiner, E.A.3
|